Phil Ambery

Phil Ambery

Company: AstraZeneca

Job title: Global Clinical Head, CVRM


Patient Segmentation & Enhancing Understanding of Efficacy: Leveraging Machine Learning to Predict Fast Progressors & the Value of MRI 1:30 pm

Constructing a model to predict survival time of patients with NASH and/or portal hypertension, and identify fast progressors Evaluating current performance in treating patients with cirrhosis and features of portal hypertension, real-world evidence Non-invasive biomarkers for portal hypertension: HVPG vs integrating MRI into clinical trials to monitor therapeutic efficacyRead more

day: Day 2 Stream 2 PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.